Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zoom
ZM
|
+$806M |
| 2 |
AbbVie
ABBV
|
+$481M |
| 3 |
T-Mobile US
TMUS
|
+$464M |
| 4 |
Kroger
KR
|
+$430M |
| 5 |
Baidu
BIDU
|
+$423M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$1.35B |
| 2 |
AGN
Allergan plc
AGN
|
+$1.26B |
| 3 |
S
Sprint Corporation
S
|
+$675M |
| 4 |
Amgen
AMGN
|
+$488M |
| 5 |
Humana
HUM
|
+$450M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 23.76% |
| 2 | Technology | 16.41% |
| 3 | Consumer Staples | 10.58% |
| 4 | Consumer Discretionary | 10.13% |
| 5 | Communication Services | 9.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PARAA
1651
DELISTED
Paramount Global Class A
PARAA
| $4.98M | ﹤0.01% |
194,376
-145,200
| -43% | -$3.24M |
|
1652
Aviat Networks
AVNW
$287M
| $4.97M | ﹤0.01% |
544,170
-27,600
| -5% | -$172K |
|
1653
Stratasys
SSYS
$781M
| $4.96M | ﹤0.01% |
+312,732
| New | +$5.29M |
|
1654
Northeast Bank
NBN
$1.15B
| $4.95M | ﹤0.01% |
282,045
-7,300
| -3% | -$111K |
|
|
LEAF
1655
DELISTED
Leaf Group Ltd.
LEAF
| $4.93M | ﹤0.01% |
1,343,967
+256,100
| +24% | +$532K |
|
1656
Bloomin' Brands
BLMN
$903M
| $4.93M | ﹤0.01% |
462,500
+416,023
| +895% | +$4.3M |
|
1657
Select Water Solutions
WTTR
$2.69B
| $4.92M | ﹤0.01% |
1,004,342
+131,800
| +15% | +$604K |
|
1658
Cabot Corp
CBT
$4.54B
| $4.91M | ﹤0.01% |
132,600
+83,000
| +167% | +$2.78M |
|
1659
BCB Bancorp
BCBP
$163M
| $4.89M | ﹤0.01% |
527,178
-9,400
| -2% | -$90.1K |
|
1660
Varex Imaging
VREX
$779M
| $4.89M | ﹤0.01% |
322,800
-41,500
| -11% | -$838K |
|
1661
Westamerica Bancorp
WABC
$1.38B
| $4.88M | ﹤0.01% |
84,931
+41,031
| +93% | +$2.39M |
|
1662
Airgain
AIRG
$72.2M
| $4.85M | ﹤0.01% |
451,936
+39,700
| +10% | +$339K |
|
|
ALTA
1663
DELISTED
Altabancorp
ALTA
| $4.84M | ﹤0.01% |
215,340
-19,300
| -8% | -$399K |
|
|
XIFR
1664
XPLR Infrastructure LP
XIFR
$1.11B
| $4.82M | ﹤0.01% |
94,000
-10,300
| -10% | -$499K |
|
1665
Bar Harbor Bankshares
BHB
$681M
| $4.82M | ﹤0.01% |
215,150
-43,100
| -17% | -$803K |
|
1666
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
$23.3B
| $4.81M | ﹤0.01% |
88,000
-23,100
| -21% | -$1.24M |
|
|
WMC
1667
DELISTED
Western Asset Mortgage Capital Corporation
WMC
| $4.81M | ﹤0.01% |
175,645
-134,931
| -43% | -$3.45M |
|
1668
Philips
PHG
$26.7B
| $4.81M | ﹤0.01% |
126,580
-218,455
| -63% | -$7.6M |
|
1669
iShares TIPS Bond ETF
TIP
$14.7B
| $4.8M | ﹤0.01% |
+39,000
| New | +$4.74M |
|
1670
Farmers National Banc Corp
FMNB
$966M
| $4.8M | ﹤0.01% |
404,400
-36,504
| -8% | -$422K |
|
1671
Terex
TEX
$7.76B
| $4.77M | ﹤0.01% |
254,100
+54,000
| +27% | +$859K |
|
|
SBBP
1672
DELISTED
Strongbridge Biopharma plc.
SBBP
| $4.74M | ﹤0.01% |
1,254,600
+290,272
| +30% | +$870K |
|
1673
Jabil
JBL
$38B
| $4.74M | ﹤0.01% |
147,600
-1,253,544
| -89% | -$36.1M |
|
1674
Verisk Analytics
VRSK
$23.6B
| $4.73M | ﹤0.01% |
+27,800
| New | +$4.39M |
|
|
GDEN
1675
DELISTED
Golden Entertainment
GDEN
| $4.73M | ﹤0.01% |
530,096
-268,404
| -34% | -$2.5M |
|
Similar funds
Jim Simons's Q2 2020 Portfolio in Review
As of Q2 2020, Jim Simons held 3,987 positions worth $116B, up 13% from $103B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Jim Simons withdrew a net $8.24B in Q2 2020, closing 596 positions and reducing 1,366 holdings. Its most notable exit was Allergan plc, an estimated $1.26B position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 24% of assets, down from 26% a quarter earlier, followed by Technology and Consumer Staples.
Against the trend, Jim Simons opened a new position in Uber worth $187M.
- Jim Simons's largest Q2 2020 buy was Uber: 6,030,316 shares worth $187M.
- Jim Simons added most to Zoom in Q2 2020, an estimated $806M increase.
- Jim Simons's biggest Q2 2020 reduction was Bristol-Myers Squibb, cutting an estimated $1.35B.
- Jim Simons fully exited Allergan plc in Q2 2020, selling an estimated $1.26B.
- Jim Simons's ten largest holdings make up 14% of its $116B portfolio in Q2 2020.
- Jim Simons opened 584 new positions and closed 596 in Q2 2020.
- Jim Simons's portfolio value rose 13% quarter-over-quarter to $116B.
Based on Renaissance Technologies's 13F filing for Q2 2020, filed 13 Aug 2020.